Nana Kojima
Minato, 1058512, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Timing of symptom onset during 60-min interval oral food challenges in children.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: September 02, 2025
In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept.
Journal: Pharmaceutical research
Published: June 25, 2023
In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.
Journal: Pharmaceutical research
Published: January 05, 2023
Development of an optimized and practical pharmacokinetics/pharmacodynamics analysis method for aztreonam/nacubactam against carbapenemase-producing K. pneumoniae.
Journal: The Journal of antimicrobial chemotherapy
Published: August 23, 2022
Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA.
Journal: Pharmaceutical research
Published: July 24, 2022
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
Journal: Pharmaceutical research
Published: August 19, 2021
The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
The optimal trough-guided monitoring of vancomycin in children: Systematic review and meta-analyses.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 06, 2020
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Journal: BMC infectious diseases
Published: September 26, 2020
Pharmacokinetics/Pharmacodynamics Evaluation of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli In Vitro and In Vivo in a Murine Thigh Infection Model.
Journal: Pharmaceutical research
Published: August 24, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026